Netherton Syndrome

·MeSH: Netherton Syndrome

Prevalence

0.5 / 100K

8 drugs in development·3 companies·5 clinical trials

Drug Pipeline by Phase

Compare drugs

ATR-12 vs BCX17725ATR-12 vs qrx003ATR-12 vs qrx003-2% lotion

Frequently asked questions

How many drugs are in development for Netherton Syndrome?

BioSniper tracks 8 drugs in development for Netherton Syndrome across 3 companies.

How many clinical trials target Netherton Syndrome?

There are 5 clinical trials targeting Netherton Syndrome tracked by BioSniper.

What is the prevalence of Netherton Syndrome?

The estimated prevalence of Netherton Syndrome is approximately 0.5 per 100,000 population.

Deep-dive into Netherton Syndrome

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Netherton Syndrome — Drugs in Development & Clinical Trials | BioSniper